Mink Therapeutics Inc (INKT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Operating Expenses | 5,500 | 5,224 | 6,343 | 5,854 | 7,889 |
| Operating Income | -5,500 | -5,224 | -6,343 | -5,854 | -7,889 |
| Other Income | 42 | 107 | 146 | 168 | 120 |
| Pre-tax Income | -5,459 | -5,116 | -6,197 | -5,686 | -7,770 |
| Net Income Continuous | -5,459 | -5,116 | -6,197 | -5,686 | -7,770 |
| Net Income | $-5,459 | $-5,116 | $-6,197 | $-5,686 | $-7,770 |
| EPS Basic Total Ops | -1.54 | -1.50 | -1.80 | -1.70 | -2.30 |
| EPS Basic Continuous Ops | -1.58 | -1.48 | -1.80 | -1.67 | -2.30 |
| EPS Diluted Total Ops | -1.54 | -1.50 | -1.80 | -1.70 | -2.30 |
| EPS Diluted Continuous Ops | -1.58 | -1.48 | -1.80 | -1.67 | -2.30 |
| EBITDA(a) | $-5,447 | $-5,170 | $-6,291 | $-5,808 | $-7,851 |